GlucoModicum today unveiled Sofio, which it labels the world's first needle-free glucose monitor based on magneto-hydrodynamics (MHD).

DexCom, Inc. reduced its 2024 revenue guidance following a decline in new U.S. customers and revenue per customer, leading to a sharp share price drop, despite $750 million share buyback. DexCom faces ...

The U.S. Food and Drug Administration (FDA) has granted permission to sell Dexcom's glucose monitoring device ' Stelo ' without a prescription. Stelo is scheduled to ...

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...

SAN FRANCISCO – It's quite difficult to maintain rapid growth as a company gets very large, since it takes more to move the needle on an increasingly bigger revenue base. But continuous glucose ...

HOPKINTON – His devices are never far away. Eye roll if you want, but this is one case where screen time has no limits. Yes, an iPhone is involved. Also never far from reach: a Dexcom, an Omnipod ...